135 related articles for article (PubMed ID: 9687008)
1. Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors.
Geiger J; Hönig-Liedl P; Schanzenbächer P; Walter U
Eur J Pharmacol; 1998 Jun; 351(2):235-46. PubMed ID: 9687008
[TBL] [Abstract][Full Text] [Related]
2. Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors.
Gachet C; Cattaneo M; Ohlmann P; Hechler B; Lecchi A; Chevalier J; Cassel D; Mannucci PM; Cazenave JP
Br J Haematol; 1995 Oct; 91(2):434-44. PubMed ID: 8547091
[TBL] [Abstract][Full Text] [Related]
3. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
[TBL] [Abstract][Full Text] [Related]
4. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets.
Daniel JL; Dangelmaier C; Jin J; Ashby B; Smith JB; Kunapuli SP
J Biol Chem; 1998 Jan; 273(4):2024-9. PubMed ID: 9442039
[TBL] [Abstract][Full Text] [Related]
6. Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: a historical perspective.
Packham MA; Mustard JF
Semin Thromb Hemost; 2005 Apr; 31(2):129-38. PubMed ID: 15852216
[TBL] [Abstract][Full Text] [Related]
7. On the mechanism of plasmin-induced platelet aggregation. Implications of the dual role of granule ADP.
Ishii-Watabe A; Uchida E; Mizuguchi H; Hayakawa T
Biochem Pharmacol; 2000 Jun; 59(11):1345-55. PubMed ID: 10751543
[TBL] [Abstract][Full Text] [Related]
8. P2T purinoceptors: ADP receptors on platelets.
Hourani SM; Hall DA
Ciba Found Symp; 1996; 198():53-64; discussion 64-70. PubMed ID: 8879818
[TBL] [Abstract][Full Text] [Related]
9. The roles of P(2X1)and P(2T AC)receptors in ADP-evoked calcium signalling in human platelets.
Sage SO; Yamoah EH; Heemskerk JW
Cell Calcium; 2000 Aug; 28(2):119-26. PubMed ID: 10970768
[TBL] [Abstract][Full Text] [Related]
10. No requirement of P2X1 purinoceptors for platelet aggregation.
Takano S; Kimura J; Matsuoka I; Ono T
Eur J Pharmacol; 1999 May; 372(3):305-9. PubMed ID: 10395026
[TBL] [Abstract][Full Text] [Related]
11. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel.
Hechler B; Eckly A; Ohlmann P; Cazenave JP; Gachet C
Br J Haematol; 1998 Dec; 103(3):858-66. PubMed ID: 9858246
[TBL] [Abstract][Full Text] [Related]
12. The P2 receptors in platelet function.
Hechler B; Cattaneo M; Gachet C
Semin Thromb Hemost; 2005 Apr; 31(2):150-61. PubMed ID: 15852218
[TBL] [Abstract][Full Text] [Related]
13. Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine.
Savi P; Laplace MC; Maffrand JP; Herbert JM
J Pharmacol Exp Ther; 1994 May; 269(2):772-7. PubMed ID: 8182545
[TBL] [Abstract][Full Text] [Related]
14. P2Y12, a new platelet ADP receptor, target of clopidogrel.
Herbert JM; Savi P
Semin Vasc Med; 2003 May; 3(2):113-22. PubMed ID: 15199474
[TBL] [Abstract][Full Text] [Related]
15. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.
Hall DA; Hourani SM
Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360
[TBL] [Abstract][Full Text] [Related]
16. Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel.
Geiger J; Brich J; Hönig-Liedl P; Eigenthaler M; Schanzenbächer P; Herbert JM; Walter U
Arterioscler Thromb Vasc Biol; 1999 Aug; 19(8):2007-11. PubMed ID: 10446085
[TBL] [Abstract][Full Text] [Related]
17. The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1.
Gachet C; Cazenave JP; Ohlmann P; Bouloux C; Defreyn G; Driot F; Maffrand JP
Biochem Pharmacol; 1990 Dec; 40(12):2683-7. PubMed ID: 2175608
[TBL] [Abstract][Full Text] [Related]
18. P2y(12), a new platelet ADP receptor, target of clopidogrel.
Savi P; Labouret C; Delesque N; Guette F; Lupker J; Herbert JM
Biochem Biophys Res Commun; 2001 May; 283(2):379-83. PubMed ID: 11327712
[TBL] [Abstract][Full Text] [Related]
19. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
Sugidachi A; Asai F; Ogawa T; Inoue T; Koike H
Br J Pharmacol; 2000 Apr; 129(7):1439-46. PubMed ID: 10742300
[TBL] [Abstract][Full Text] [Related]
20. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
Hourani SM; Hall DA; Nieman CJ
Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
